PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy

Prostate-specific membrane antigen (PSMA) has been the subject of extensive investigation in the past two decades as a promising molecular target for prostate cancer (PCa). Its appealing molecular features have enabled the development of a novel diagnostic and therapeutic—thus “theranostic”—approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Wallace, Griffiths, Kelly, Barata, Pedro C., Paller, Channing J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352725/
https://www.ncbi.nlm.nih.gov/pubmed/32466595
http://dx.doi.org/10.3390/cancers12061367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352725/
https://www.ncbi.nlm.nih.gov/pubmed/32466595
http://dx.doi.org/10.3390/cancers12061367

Ejemplares similares